807 related articles for article (PubMed ID: 25824848)
21. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
22. [Clinical characteristics of "classical" and "non-classical" paraneoplastic neurological syndrome].
Lyu XY; Wang GP; Tang QQ; Cheng ZZ; Gui W; Tian YH
Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(9):615-619. PubMed ID: 33685041
[No Abstract] [Full Text] [Related]
23. [Paraneoplastic neurological syndromes in 2008].
Honnorat J
Rev Neurol (Paris); 2009 May; 165 Suppl 3():S59-65. PubMed ID: 19524096
[TBL] [Abstract][Full Text] [Related]
24. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
[TBL] [Abstract][Full Text] [Related]
25. Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome.
Michalak S; Cofta S; Piatek A; Rybacka J; Wysocka E; Kozubski W
Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):156-61. PubMed ID: 20156748
[TBL] [Abstract][Full Text] [Related]
26. [Onconeural antibodies as a tool for diagnosis of malignant tumors and paraneoplastic neurological disorders].
Belousov PV; Shebzukhov IuV; Nedospasov SA; Kuprash DV
Mol Gen Mikrobiol Virusol; 2007; (2):6-13. PubMed ID: 17598451
[TBL] [Abstract][Full Text] [Related]
27. [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations].
Dalmau J; Porta-Etessam J
Rev Neurol; 2000 Dec 16-31; 31(12):1213-9. PubMed ID: 11205562
[TBL] [Abstract][Full Text] [Related]
28. Immunophenotypical characterization of paraneoplastic neurological syndrome patients: a multicentric study.
Lorusso L; Precone V; Hart IK; Giometto B; Pezzani R; Ngonga GK; Ngonga GKNK; Paolacci S; Ferrari D; Ricevuti G; Marshall E; Bertelli M
J Biosci; 2021; 46():. PubMed ID: 33709965
[TBL] [Abstract][Full Text] [Related]
29. Antibody to CCDC104 is associated with a paraneoplastic antibody to CDR2 (anti-Yo).
Totland C; Bredholt G; Haugen M; Haukanes BI; Vedeler CA
Cancer Immunol Immunother; 2010 Feb; 59(2):231-7. PubMed ID: 19680650
[TBL] [Abstract][Full Text] [Related]
30. [Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis].
Yamamoto T; Tsuji S
Brain Nerve; 2010 Aug; 62(8):838-51. PubMed ID: 20714032
[TBL] [Abstract][Full Text] [Related]
31. Managing paraneoplastic neurological disorders.
de Beukelaar JW; Sillevis Smitt PA
Oncologist; 2006 Mar; 11(3):292-305. PubMed ID: 16549814
[TBL] [Abstract][Full Text] [Related]
32. Paraneoplastic antibody during follow-up of a patient with anti-Ri-associated paraneoplastic neurological syndrome.
Stich O; Rasiah C; Rauer S
Acta Neurol Scand; 2009 May; 119(5):338-40. PubMed ID: 18822086
[TBL] [Abstract][Full Text] [Related]
33. Screening for well-characterized paraneoplastic antineuronal antibodies in multiple sclerosis.
Stich O; Murek C; Rasiah C; Rauer S
Int J Neurosci; 2011 Aug; 121(8):477-9. PubMed ID: 21663382
[TBL] [Abstract][Full Text] [Related]
34. Parkinsonism and dysautonomia with anti-CV2/CRMP5 associated paraneoplastic neurological syndromes mimicking multiple system atrophy: a case report.
Song J; Zhang Y; Lang Y; Wang YH; Shao J; Cui L
BMC Neurol; 2021 Oct; 21(1):408. PubMed ID: 34702214
[TBL] [Abstract][Full Text] [Related]
35. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects.
Storstein A; Vedeler CA
Adv Clin Chem; 2007; 44():143-85. PubMed ID: 17682342
[TBL] [Abstract][Full Text] [Related]
36. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.
Vedeler CA; Antoine JC; Giometto B; Graus F; Grisold W; Hart IK; Honnorat J; Sillevis Smitt PA; Verschuuren JJ; Voltz R;
Eur J Neurol; 2006 Jul; 13(7):682-90. PubMed ID: 16834698
[TBL] [Abstract][Full Text] [Related]
37. Clinical analysis of anti-Ma2-associated encephalitis.
Dalmau J; Graus F; Villarejo A; Posner JB; Blumenthal D; Thiessen B; Saiz A; Meneses P; Rosenfeld MR
Brain; 2004 Aug; 127(Pt 8):1831-44. PubMed ID: 15215214
[TBL] [Abstract][Full Text] [Related]
38. Onconeural antibodies are essential to diagnose paraneoplastic neurological syndromes.
Honnorat J
Acta Neurol Scand Suppl; 2006; 183():64-8. PubMed ID: 16637934
[TBL] [Abstract][Full Text] [Related]
39. [Paraneoplastic neurological syndromes].
Antoine JC; Camdessanché JP
Presse Med; 2007 Oct; 36(10 Pt 2):1418-26. PubMed ID: 17399944
[TBL] [Abstract][Full Text] [Related]
40. Avidity of onconeural antibodies is of clinical relevance.
Totland C; Ying M; Haugen M; Mazengia K; Storstein A; Aarseth J; Martinez A; Vedeler C
Cancer Immunol Immunother; 2013 Aug; 62(8):1393-6. PubMed ID: 23733227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
